Non-Hodgkin Lymphoma Latest Advances

Follicular lymphoma and the microenvironment: potential targets and biomarkers.

Journal: Expert review of clinical immunology

Published: September 08, 2026

Research progress in MALT lymphoma of the ocular adnexa

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: September 07, 2026

Efficacy and safety analysis of the salvage treatment for diffuse large B-cell lymphoma after the failure of anti-CD19 CAR-T therapy

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Aggressive B-cell lymphomas with MYC gene cluster amplification: a clinicopathological analysis of eight cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: September 07, 2026

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Intravascular large B-cell lymphoma with reversible central hypopituitarism.

Journal: BMJ case reports

Published: September 07, 2026

The prognostic value of IGHV gene segment usage in advanced-stage follicular lymphoma with bone marrow infiltration

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

From syndrome of inappropriate antidiuretic hormone secretion deficiency to excess - Challenges and solutions in a unique case

Journal: Nutricion hospitalaria

Published: September 07, 2026

The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Chinese expert consensus on the diagnosis and treatment of Burkitt lymphoma (2026)

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Precision medicine era: a molecular pathological diagnostic pathway for B-cell lymphomas

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: September 07, 2026

A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Non-Hodgkin Lymphoma Latest Advances

Find the Latest Research About Non-Hodgkin Lymphoma

Follicular lymphoma and the microenvironment: potential targets and biomarkers.

Follicular lymphoma and the microenvironment: potential targets and biomarkers.

Research progress in MALT lymphoma of the ocular adnexa

Research progress in MALT lymphoma of the ocular adnexa

Efficacy and safety analysis of the salvage treatment for diffuse large B-cell lymphoma after the failure of anti-CD19 CAR-T therapy

Efficacy and safety analysis of the salvage treatment for diffuse large B-cell lymphoma after the failure of anti-CD19 CAR-T therapy

Aggressive B-cell lymphomas with MYC gene cluster amplification: a clinicopathological analysis of eight cases

Aggressive B-cell lymphomas with MYC gene cluster amplification: a clinicopathological analysis of eight cases

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Intravascular large B-cell lymphoma with reversible central hypopituitarism.

Intravascular large B-cell lymphoma with reversible central hypopituitarism.

The prognostic value of IGHV gene segment usage in advanced-stage follicular lymphoma with bone marrow infiltration

The prognostic value of IGHV gene segment usage in advanced-stage follicular lymphoma with bone marrow infiltration

From syndrome of inappropriate antidiuretic hormone secretion deficiency to excess - Challenges and solutions in a unique case

From syndrome of inappropriate antidiuretic hormone secretion deficiency to excess - Challenges and solutions in a unique case

The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

Chinese expert consensus on the diagnosis and treatment of Burkitt lymphoma (2026)

Chinese expert consensus on the diagnosis and treatment of Burkitt lymphoma (2026)

Precision medicine era: a molecular pathological diagnostic pathway for B-cell lymphomas

Precision medicine era: a molecular pathological diagnostic pathway for B-cell lymphomas

A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities

A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities